Dafo 10mg (14 Tablet / Pack)

An SGLT2 inhibitor tablet used for glycemic control and cardiovascular support.

PKR 210.00

You save: PKR 0

Quantity:

SKU: DAFO_10MG_14_TABLET_PACK

Category: Tablets & Capsules

Dafo 10mg Tablets contain Dapagliflozin, a potent, highly selective, and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2). It works independently of insulin by blocking glucose reabsorption in the proximal renal tubules of the kidneys, thereby promoting the excretion of excess glucose through the urine to lower blood sugar levels and provide cardiovascular benefits.

Purpose

Used to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of heart failure hospitalization.

Ingredients

Dapagliflozin 10mg

Warnings

Monitor volume status closely, as SGLT2 inhibitors cause osmotic diuresis which can lead to symptomatic hypotension or dehydration.

Assess renal function parameters thoroughly before initiating therapy and periodically throughout the treatment.

Monitor for signs of diabetic ketoacidosis (DKA) even if blood glucose levels are near normal; discontinue immediately if DKA is suspected.

Instruct patients to maintain meticulous perineal hygiene to minimize the risk of genital mycotic infections and urinary tract infections.

Side Effects

Increased frequency of urination, polyuria, or mild localized thirst.

Genital mycotic infections (such as vulvovaginal candidiasis or balanitis) and urinary tract infections.

Mild transient drops in blood pressure, dizziness, or lightheadedness upon standing.

Minor alterations in serum lipid profiles or serum creatinine levels.